Deal Library / Pharma BD Deal Intelligence
Pharma Deals of 2021
The Pharma Closeout tracks 272 deals, $185.3B in disclosed deal value, 25 with a post-close Outcome Score for the year 2021.
Median Critic Score: 73 · Median Outcome Score: 58
Best outcome: Merck & Co. Inc. / Acceleron Pharma Inc. (90) · Weakest outcome: Pfizer Inc. / Trillium Therapeutics Inc. (21)
All 272 deals
- Merck & Co. Inc. / Acceleron Pharma Inc. — 2021 · $11.5B · Worked — the deal delivered on its rationale.
- Amgen Inc. / Five Prime Therapeutics — 2021 · $1.9B · Worked — the deal delivered on its rationale.
- Thermo Fisher Scientific Inc. / PPD Inc. — 2021 · $17.4B · Worked — the deal delivered on its rationale.
- Pfizer Inc. / Arvinas, Inc. — 2021 · $2.4B · Worked — the deal delivered on its rationale.
- Jazz Pharmaceuticals PLC / GW Pharmaceuticals — 2021 · $7.2B · Worked — the deal delivered on its rationale.
- Sanofi SA / Amunix Pharmaceuticals Inc. — 2021 · $1.2B · Worked — the deal delivered on its rationale.
- AstraZeneca PLC / Ionis Pharmaceuticals, Inc. — 2021 · $4.2B · Largely worked — most objectives met.
- Horizon Therapeutics plc / Viela Bio Inc. — 2021 · $3.0B · Largely worked — most objectives met.
- Novo Nordisk A/S / Dicerna Pharmaceuticals, Inc. — 2021 · $3.3B · Largely worked — most objectives met.
- Pfizer Inc. / Arena Pharmaceuticals — 2021 · $6.7B · Largely worked — most objectives met.
- Sanofi SA / Kadmon Holdings Inc. — 2021 · $1.9B · Largely worked — most objectives met.
- Roche Holding AG / GenMark Diagnostics — 2021 · $1.8B · Largely worked — most objectives met.
- CSL Limited / Vifor Pharma Group — 2021 · $11.7B · Mixed — partial payoff, real shortfalls.
- ICON plc / PRA Health Sciences Inc. — 2021 · $12.0B · Mixed — partial payoff, real shortfalls.
- Sanofi SA / Kymab Ltd — 2021 · $1.4B · Mixed — partial payoff, real shortfalls.
- Merck & Co. Inc. / Pandion Therapeutics — 2021 · $1.9B · Mixed — partial payoff, real shortfalls.
- ProPhase Labs / Nebula Genomics — 2021 · $15M · Mixed — partial payoff, real shortfalls.
- Baxter International Inc. / Hillrom Holdings Inc. — 2021 · $12.4B · Mixed — partial payoff, real shortfalls.
- Bristol-Myers Squibb Company / Eisai Co., Ltd. — 2021 · $3.1B · Mixed — partial payoff, real shortfalls.
- Novartis AG / BeiGene Ltd. — 2021 · $2.2B · Underwhelmed — fell short of the thesis.
- Sanofi SA / Translate Bio Inc. — 2021 · $3.2B · Underwhelmed — fell short of the thesis.
- Agilent Technologies Inc. / Resolution Bioscience Inc. — 2021 · $695M · Underwhelmed — fell short of the thesis.
- GlaxoSmithKline plc / iTeos Therapeutics S.A. — 2021 · $2.1B · Did not work — the deal failed to deliver.
- Novartis AG / Gyroscope Therapeutics — 2021 · $1.5B · Did not work — the deal failed to deliver.
- Pfizer Inc. / Trillium Therapeutics Inc. — 2021 · $2.3B · Did not work — the deal failed to deliver.
- Eli Lilly and Company / MiNA Therapeutics Limited — 2021
- Thermo Fisher Scientific Inc. / Henogen S.A. (Novasep viral vector business) — 2021 · $875M
- Akebia Therapeutics, Inc. / Cyclerion Therapeutics, Inc. — 2021
- Coeptis Pharmaceuticals, Inc. / VyGen-Bio, Inc. — 2021
- Roivant Sciences Ltd. / Pfizer Inc. / Priovant Therapeutics — 2021 · $300M
- Boehringer Ingelheim International GmbH / Abexxa Biologics Inc. — 2021
- Biohaven Pharmaceutical Holding Company Ltd. / Kleo Pharmaceuticals, Inc. — 2021
- Eli Lilly and Company / ALX Oncology — 2021
- Ji Xing Pharmaceuticals / Oyster Point Pharma, Inc. — 2021
- Sarepta Therapeutics Inc. / Genevant Sciences — 2021
- Mirati Therapeutics, Inc. / Verastem Oncology — 2021
- Arch Biopartners Inc. / Telara Pharma — 2021
- Almirall, S.A. / Tyris Therapeutics — 2021
- Eli Lilly and Company / Protomer Technologies — 2021 · $1.0B
- Merck & Co. Inc. / Io Biotech — 2021
- CASI Pharmaceuticals, Inc. / Cleave Therapeutics, Inc. — 2021
- Janssen Pharmaceuticals, Inc. / TenNor Therapeutics (Suzhou) Limited — 2021
- Amgen Inc. / Teneobio, Inc. — 2021 · $2.5B
- OBI Pharma, Inc / Biosion, Inc. — 2021
- Eli Lilly and Company / Foghorn Therapeutics Inc. — 2021 · $1.7B
- Sumitomo Dainippon Pharma Co., Ltd. / Otsuka Pharmaceutical Co., Ltd. — 2021 · $270M
- Ethypharm / Altan Pharma — 2021
- Aguettant / AFT Pharmaceuticals — 2021
- Arbutus Biopharma Corporation / Antios Therapeutics, Inc. — 2021
- Century Therapeutics / Outpace Bio — 2021
- Tonix Pharmaceuticals Holding Corp. / OyaGen, Inc. — 2021
- Oncorus, Inc. / Gaeta Therapeutics Ltd. — 2021
- Pyxis Oncology / Pfizer Inc. — 2021
- Chinook Therapeutics Inc. / Evotec SE — 2021
- Roche / Treos Bio Limited — 2021
- Targovax ASA / Papyrus Therapeutics — 2021
- Eli Lilly and Company / Regor Therapeutics Group — 2021
- DIACCURATE / BIOKINESIS — 2021
- Bristol Myers Squibb / Antengene Corporation Limited — 2021
- Arvinas / Insilico Medicine — 2021
- Eli Lilly and Company / Kumquat Biosciences, Inc. — 2021 · $2.1B
- Sanofi SA / Origimm Biotechnology GmbH — 2021 · $170M
- Shanghai Fosun Pharmaceutical Development Ltd. / Kintor Pharmaceutical Limited — 2021
- Amolyt Pharma / PeptiDream Inc. — 2021
- Imugene Ltd / Celularity Inc — 2021
- Merck & Co. Inc. / Sotio — 2021
- Roche Holding AG / Adaptimmune Therapeutics plc — 2021 · $3.3B
- Volastra Therapeutics / Dewpoint Therapeutics — 2021
- Deciphera Pharmaceuticals / Sprint Bioscience AB — 2021 · $277M
- Ascentage Pharma / Clover Biopharmaceuticals, Ltd. — 2021
- EQRx / Turning Point Therapeutics Inc. — 2021
- Janssen Research & Development, LLC / ESSA Pharma Inc. — 2021
- Amgen / EVOQ Therapeutics — 2021
- Winhealth Pharma Group / TWi Biotechnology, Inc. — 2021
- Advaccine Biopharmaceuticals Suzhou Co., Ltd. / INOVIO — 2021
- STADA Arzneimittel AG / Calliditas Therapeutics AB — 2021
- Catalent, Inc. / Bettera Holdings, LLC — 2021 · $1.0B
- Innovent Biologics, Inc. / Laekna Therapeutics Shanghai Co., Ltd. — 2021
- Sanofi SA / Tidal Therapeutics, Inc. — 2021 · $470M
- Eli Lilly and Company / Lycia Therapeutics, Inc. — 2021
- TeamedOn International, Inc. / Applied Genetic Technologies Corporation — 2021
- Takeda Pharmaceutical Company Ltd. / Novavax Inc. — 2021 · $350M
- AstraZeneca plc / F-star Therapeutics, Inc. — 2021
- Organon & Co. / Forendo Pharma — 2021 · $954M
- Alpha Biopharma Inc. / Wugen Inc. — 2021
- Astellas Pharma Inc. / ESSA Pharma Inc. — 2021
- BioMarin Pharmaceutical Inc. / Skyline Therapeutics — 2021
- Ionis Pharmaceuticals, Inc. / Bicycle Therapeutics plc — 2021
- Context Therapeutics / Integral Molecular — 2021
- Inmagene Biopharmaceuticals / Hutchison China MediTech Limited — 2021
- Relay Therapeutics, Inc. / ZebiAI — 2021
- Takeda Pharmaceutical Company Ltd. / GammaDelta Therapeutics Limited — 2021 · $350M
- Zai Lab Limited / Mirati Therapeutics, Inc. — 2021
- Drogsan Pharmaceuticals / Rockwell Medical, Inc. — 2021
- Pharming Group N.V. / Orchard Therapeutics — 2021
- PT Etana Biotechnologies Indonesia / Kintor Pharmaceutical Limited — 2021
- Phio Pharmaceuticals Corp. / AgonOx, Inc. — 2021
- ConserV Bioscience Limited / etherna immunotherapies NV — 2021
- Eli Lilly and Company / Blacksmith Medicines, Inc. — 2021 · $300M
- Oncternal Therapeutics, Inc. / Celularity Inc — 2021
- AstraZeneca PLC / Caelum Biosciences — 2021 · $500M
- AzurRx BioPharma, Inc. / First Wave Bio, Inc. — 2021
- Huyabio International / Shanghai Jemincare Pharmaceutical Co., Ltd. — 2021
- Helsinn Group / BridgeBio Pharma, Inc. — 2021
- AbbVie Inc. / SpringWorks Therapeutics, Inc. — 2021
- Teva Israel Ltd. / Quantum Genomics — 2021 · $11M
- Eli Lilly and Company / Rigel Pharmaceuticals, Inc. — 2021 · $960M
- Nuance Pharma / Antibe Therapeutics Inc. — 2021
- M8 Pharmaceuticals / Hennig Arzneimittel — 2021
- SparingVision / Intellia Therapeutics, Inc. — 2021
- POINT Biopharma Inc. / CanProbe — 2021
- Hansoh Pharmaceutical Group Company Limited / SCYNEXIS, Inc. — 2021 · $122M
- Rancho Santa Fe Bio, Inc. / Sanofi — 2021
- Novartis / Artios Pharma Limited — 2021
- Novavax Inc. / SK Bioscience Co., Ltd. — 2021 · $300M
- Neurocrine Biosciences Inc. / Sentia Medical Sciences Inc. — 2021
- Incyte / Syndax Pharmaceuticals, Inc. — 2021
- Merck & Co. Inc. / HOOKIPA Pharma Inc. — 2021
- Janssen Biotech, Inc. / Vor Biopharma — 2021
- Walvax Biotechnology / Sirnaomics Biopharmaceuticals (Suzhou) Co. Ltd. — 2021
- TRACON Pharmaceuticals / Eucure Biopharma — 2021
- Gilead Sciences, Inc. / Vir Biotechnology Inc. — 2021
- AstraZeneca / Integral Molecular — 2021
- uniQure N.V. / Corlieve Therapeutics — 2021
- Gritstone Oncology, Inc. / Genevant Sciences — 2021
- Innovent Biologics (HK) Limited / UNION therapeutics A/S — 2021
- Roche Holding AG / Shape Therapeutics Inc. — 2021 · $3.0B
- Sanofi SA / Owkin, Inc. — 2021 · $270M
- Angelini Pharma / Arvelle Therapeutics — 2021 · $960M
- Aridis Pharmaceuticals, Inc. / AstraZeneca — 2021
- Hansoh (Shanghai) Healthtech Company Limited / Keros Therapeutics, Inc. — 2021
- Haisco Pharmaceutical Group Co., Ltd. / Biosplice Therapeutics, Inc. — 2021
- GlaxoSmithKline plc / Vir Biotechnology Inc. — 2021 · $345M
- F. Hoffmann-La Roche Ltd. / Tempest Therapeutics, Inc. — 2021
- FibroGen, Inc. / HiFiBiO Therapeutics — 2021
- ALX Oncology Holdings Inc. / Tallac Therapeutics, Inc. — 2021
- Selecta Biosciences, Inc. / Genovis — 2021
- Enveric Biosciences / MagicMed Industries Inc. — 2021
- Agenus Inc. / Nelum Corp. — 2021
- Aequus Pharmaceuticals Inc. / reVision Therapeutics, Inc. — 2021
- Daiichi Sankyo Company, Limited / LogicBio Therapeutics Inc. — 2021
- Selecta Biosciences, Inc. / Cyrus Biotechnology, Inc. — 2021
- Biogen Inc. / Mirimus, Inc. — 2021
- Roche / Synlogic, Inc. — 2021
- Eli Lilly and Company / Asahi Kasei Pharma — 2021 · $230M
- ImmunityBio, Inc. / iosBio — 2021
- Cytovia Therapeutics, Inc. / Cellectis — 2021
- ESSA Pharma Inc. / Bayer — 2021
- Intas Pharmaceuticals / Foresee Pharmaceuticals — 2021
- Julphar / Quantum Genomics — 2021
- Spark Therapeutics Inc. / Senti Biosciences — 2021
- Precision BioSciences, Inc. / Tiziana Life Sciences plc — 2021
- Elpiscience Biopharmaceuticals / TRIGR Therapeutics, Inc. — 2021
- Newsoara BioPharma Co., Ltd. / Genelux Corporation — 2021
- Helsinn Group / QED Therapeutics, Inc. — 2021
- Astellas Pharma Inc. / Dyno Therapeutics, Inc. — 2021
- Bristol Myers Squibb / Molecular Templates, Inc. — 2021
- Spark Therapeutics / CombiGene AB — 2021
- Hyloris Pharmaceuticals SA / Purna Female Healthcare — 2021
- Takeda Pharmaceutical Company Limited / BridGene Biosciences, Inc. — 2021
- Enveric Biosciences / Diverse Biotech — 2021
- Torii Pharmaceutical Co., Ltd. / Verrica Pharmaceuticals Inc. — 2021
- Merck KGaA / Debiopharm — 2021 · $1.1B
- Turret Capital Management / Genexine, Inc. — 2021
- Cellectar Biosciences, Inc. / LegoChemBio — 2021
- Dr. Falk Pharma GmbH / Renexxion Ireland Ltd. — 2021
- EQT Private Capital / Recipharm AB — 2021 · $2.8B
- Qilu Pharmaceutical / Cend Therapeutics, Inc. — 2021
- Sybleu Inc. / Oncology Pharma Inc. — 2021
- Jasper Therapeutics, Inc. / AVROBIO, Inc. — 2021
- BioNTech SE / Kite Pharma (Gilead Sciences) — 2021 · $250M
- Roche Holding AG / Recursion Pharmaceuticals, Inc. — 2021 · $12.0B
- Oncoheroes Biosciences / Shepherd Therapeutics — 2021
- Innovent Biologics, Inc. / NeoCura Bio-Medical Technology Co., Ltd. — 2021
- ViiV Healthcare / Halozyme Therapeutics, Inc. — 2021
- AstraZeneca PLC / Ionis Pharmaceuticals, Inc. — 2021 · $3.6B
- CRISPR Therapeutics AG / Capsida Biotherapeutics Inc. — 2021
- Arbutus Biopharma Corporation / Vaccitech plc — 2021
- LianBio / Landos Biopharma Inc. — 2021
- MacroGenics, Inc. / Alligator Bioscience — 2021
- Qilu Pharmaceutical / Peptron, Inc. — 2021
- Cristal Therapeutics / Intravacc — 2021
- Bristol-Myers Squibb Company / Huyabio International — 2021
- Core One Labs Inc. / Akome Biotech Ltd. — 2021
- Processa Pharmaceuticals, Inc. / Ocuphire Pharma, Inc. — 2021
- VYNE Therapeutics Inc. / In4Derm Limited — 2021
- CANbridge Pharmaceuticals, Inc. / LogicBio Therapeutics Inc. — 2021
- AbbVie Inc. / Calico Life Sciences LLC — 2021 · $1.0B
- Innovent Biologics, Inc. / Bolt Biotherapeutics, Inc. — 2021
- Acasti Pharma Inc. / Grace Therapeutics, Inc. — 2021
- Surface Oncology / Vaccinex — 2021
- Haisco Pharmaceutical Group Co., Ltd. / Starton Therapeutics Inc. — 2021
- BlueRock Therapeutics LP / Senti Biosciences, Inc. — 2021
- Apollomics Inc. / Iterion Therapeutics, Inc. — 2021
- Xeris Pharmaceuticals, Inc. / Strongbridge Biopharma plc — 2021 · $267M
- Illumina, Inc. / GRAIL, Inc. — 2021 · $7.1B
- Hangzhou Chance Pharmaceuticals Co. Ltd. / Aerami Therapeutics, Inc. — 2021
- LianBio / Tarsus Pharmaceuticals, Inc. — 2021
- VectivBio Holding AG / Comet Therapeutics, Inc. — 2021
- Genmab A/S / Bolt Biotherapeutics, Inc. — 2021 · $880M
- Cantex Pharmaceuticals, Inc. / vTv Therapeutics Inc. — 2021
- SarcoMed USA Inc. / Protalix BioTherapeutics, Inc. — 2021
- Bayer AG / Vividion Therapeutics, Inc. — 2021 · $2.0B
- Aptose Biosciences Inc. / Hanmi Pharmaceutical — 2021
- Innovent Biologics, Inc. / AnHeart Therapeutics Co., Ltd. — 2021
- Takeda Pharmaceutical Company Limited / Anima Biotech — 2021
- Onward Therapeutics SA / Biomunex Pharmaceuticals SAS — 2021
- AbbVie Inc. / REGENXBIO Inc. — 2021 · $1.8B
- Faraday Pharmaceuticals, Inc. / Actimed Therapeutics Ltd — 2021
- Inhalon Biopharma, Inc. / Celltrion, Inc. — 2021
- Amgen Inc. / Rodeo Therapeutics Corporation — 2021 · $721M
- Takeda Pharmaceutical Company Limited / Denali Therapeutics Inc. — 2021
- Denovo Biopharma LLC / QIAGEN — 2021
- GlaxoSmithKline plc / Alector, Inc. — 2021 · $2.2B
- Cerevel Therapeutics / Herophilus — 2021
- Takeda Pharmaceutical Company Limited / Selecta Biosciences, Inc. — 2021
- Antengene Corporation Limited / MindRank AI — 2021
- Bridge BioPharma, Inc. / Unnatural Products, Inc. — 2021
- Sorrento Therapeutics Inc. / ACEA Therapeutics, Inc. — 2021
- Neurophth Therapeutics, Inc. / AAVnerGene Inc. — 2021
- Sentynl Therapeutics, Inc. / Cyprium Therapeutics, Inc. — 2021
- Oscotec Inc. / Beactica Therapeutics AB — 2021
- Vifor Pharma / Travere Therapeutics, Inc. — 2021
- Oyster Point Pharma, Inc. / Adaptive Phage Therapeutics — 2021
- Medexus Pharmaceuticals Inc. / medac Gesellschaft für klinische Spezialpräparate m.b.H. — 2021
- Everest Medicines Limited / AbCellera — 2021
- Oasmia Pharmaceutical AB / Kazia Therapeutics Limited — 2021
- FSD Pharma Inc. / Lucid Psycheceuticals Inc. — 2021 · $9M
- RareStone LTD / Rhythm Pharmaceuticals, Inc. — 2021
- Jasper Therapeutics, Inc. / Aruvant Sciences — 2021
- Eli Lilly and Company / Merus N.V. — 2021 · $1.7B
- Perrigo Company plc / HRA Pharma — 2021 · $2.1B
- CRISPR Therapeutics AG / Nkarta, Inc. — 2021
- Ipsen S.A. / GENFIT — 2021 · $543M
- Bright Peak Therapeutics, Inc. / Livzon Mabpharm, Inc. — 2021
- Candel Therapeutics, Inc. / Bionaut Labs — 2021
- HilleVax, Inc. / Takeda Pharmaceutical Company Limited — 2021
- Qilu Pharmaceutical / Arbutus Biopharma Corporation — 2021
- Bristol-Myers Squibb Company / Agenus Inc. — 2021 · $1.6B
- Fortress Biotech, Inc. / Fuji Yakuhin Co. Ltd. — 2021
- Jadeite Medicines, Inc. / Albireo Pharma, Inc. — 2021
- Samil Pharmaceutical Co. Ltd. / Biosplice Therapeutics, Inc. — 2021
- MorphoSys AG / Constellation Pharmaceuticals, Inc. — 2021 · $1.7B
- Antios Therapeutics, Inc. / Assembly Biosciences, Inc. — 2021
- Sciwind Biosciences Co., Ltd. / Sanofi — 2021
- Adhera Therapeutics, Inc. / Melior Pharmaceuticals II, LLC — 2021
- AbbVie / Caribou Biosciences, Inc. — 2021
- Hoth Therapeutics, Inc. / Zylö Therapeutics — 2021
- Vertex Pharmaceuticals Incorporated / Arbor Biotechnologies — 2021
- Bristol Myers Squibb / Bolt Biotherapeutics, Inc. — 2021
- Supernus Pharmaceuticals, Inc. / Adamas Pharmaceuticals, Inc. — 2021 · $450M
- BeiGene Ltd. / Asieris Pharmaceuticals — 2021
- Genentech / Novome Biotechnologies, Inc. — 2021
- Roche / Carrick Therapeutics — 2021
- Bristol-Myers Squibb Company / Immatics N.V. — 2021 · $920M
- Seelos Therapeutics, Inc. / iX Biopharma Ltd — 2021
- Pfizer Inc. / Nektar Therapeutics — 2021
- RELIEF THERAPEUTICS Holding AG / Acer Therapeutics Inc. — 2021 · $36M
- Tasly Biopharmaceuticals Co., Ltd. / Sutro Biopharma, Inc. — 2021
- Hansa Biopharma AB / argenx BV — 2021
- Biogen Inc. / Bio-Thera Solutions, Ltd. — 2021
- Apellis Pharmaceuticals, Inc. / Beam Therapeutics Inc. — 2021
- Nordic Capital / ADVANZ PHARMA Corp. Limited — 2021
- Janssen Biotech, Inc. / F-star Therapeutics, Ltd. — 2021
- Vertex Pharmaceuticals Incorporated / CRISPR Therapeutics AG — 2021 · $1.1B
- Zai Lab Limited / Blueprint Medicines Corporation — 2021
- EQRx / Absci Corporation — 2021
- Abdul Latif Jameel Health / Evelo Biosciences — 2021
- Sirtex Medical, Inc. / OncoSec Medical Incorporated — 2021
- Hansoh Pharmaceutical Group Co. Ltd. / OliX Pharmaceuticals, Inc. — 2021
- Merck & Co. Inc. / F-star Therapeutics, Inc. — 2021
- Wugen Inc. / HCW Biologics Inc. — 2021
← Deal Library ·
Interactive search ·
How we score deals